Stereotaxis nets FDA clearance for redesigned surgical robot

The company also posted weaker third-quarter results, but CEO David Fischel said orders for the new GenesisX system, when fully launched, would outpace the rate for an older model.

Medtech VC funding slows in Q3: PitchBook

The lowest level of quarterly VC funding since 2023 has tempered expectations that the sector will achieve its best year since 2021.

MMI tackles Alzheimer’s; SS Innovations advances telesurgery

MMI won FDA approval to study robotic surgery for Alzheimer’s disease. Elsewhere, SS Innovations’ CEO performed remote bypass surgery with a new console, and Procept BioRobotics’ Q3 revenue rose 43%.

Laborie inks $465M deal to buy post-childbirth device from Organon

Organon tripled sales of the bleeding-control system from 2022 to 2024 and is on track to grow sales again this year.

Congress inches towards ending shutdown with no extension of ACA subsidies

The Senate overcame a key procedural hurdle on Sunday after eight Democrats broke with their party to back a measure freeing the government from the longest funding lapse in history.

Synchron raises $200M to prepare for brain computer interface launch

The company will use the money to accelerate pivotal trials and prepare for commercial launch of the Stentrode BCI system.

Olympus to cut 2,000 jobs in endoscopy reorganization

The workforce reduction is part of a restructuring designed to improve accountability and accelerate growth and innovation.

Tidepool, Ōura partner on diabetes research

The collaboration will pair biometric data from the Oura ring with information from glucose sensors and insulin pumps.

Illumina says China is lifting export ban

However, the sequencing company said it remains on China’s unreliable entity list, and it is working toward a long-term resolution of the issue.

Supreme Court questions Trump’s tariff powers in landmark case

Several justices seemed skeptical of the Trump administration's claims of broad tariff authority under a 1977 emergency powers act.

Siemens Healthineers predicts tariff impact will double

The company expects to fully offset the negative effects of tariffs in the medium term.

Medtronic’s Jason Fontana on ramping up renal denervation

The general manager for the business says building a market is something the medtech giant knows how to do.

Most healthcare organizations face significant financial, operational impact from cyber threats: survey

More than 70% reported moderate to severe financial effects from an incident in the past two years, while nearly 60% cited clinical impacts, according to the report by Ernst & Young and Klas Research.

Zimmer CEO ‘very surprised’ by Q3 sales miss

CEO Ivan Tornos said multiple factors emerged late in the quarter that caused the shortfall.

Qiagen inks $225M single-cell buyout as CEO prepares to step down

Qiagen has identified Parse Biosciences’ technology as complementary to its sample technology and bioinformatic businesses.

Legislators object to proposed CMS payment changes for diabetes tech

In a letter to CMS Administrator Mehmet Oz, diabetes caucus leaders raised concerns that the agency’s proposals will reduce access to glucose monitors and insulin pumps.

Dexcom recalls G6 CGM app over software problem

A software defect could cause the app to terminate, resulting in missed alerts or alarms. Dexcom required users to download an update.

Health groups urge passage of bill to ease Medicare pay cuts for tests

More than 30 organizations, including AdvaMed and the American Clinical Laboratory Association, are pushing for a permanent legislative solution to stop looming Medicare payment cuts for diagnostic tests.

Olympus further clarifies device use after serious injuries and death

The update is intended to cut the risk of endobronchial combustion that has been linked to serious injuries and one death.

Edwards CFO Scott Ullem to exit post

Ullem, who has held the position for more than a decade, will transition to an advisory role after his replacement is named by mid-2026.

Dexcom execs say company has fixed G7 quality problems

After dealing with a deployment issue with glucose monitors earlier this year, interim CEO Jake Leach said improving customer service has also been a focus for the company.

Agilent selects Adam Elinoff as CFO

The appointment fills a position made available when Bob McMahon resigned as CFO on July 31.

3 takeaways from TCT 2025

Trials from Edwards, Philips and Penumbra were among the most-watched studies at the annual cardiovascular meeting.

Philips receives FDA warning letter over quality issues

The notice follows inspections of three Philips facilities that found failures to meet standards for reporting complaints and corrective actions.

US to lower China tariffs as part of trade war truce

The truce also includes de-escalating other trade actions, such as China's rare earth export controls and U.S. investigations into China-linked ships.